Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2003
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066099A1 2,4,6-triamino-1,3,5-triazine derivative
08/14/2003WO2003066060A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/14/2003WO2003066057A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153754 Gamma-aminobutyric acid (gaba); anxiolytic agents, treating sleep and seizure disorders
08/14/2003US20030153751 Inhibitors of phospholipase enzymes
08/14/2003US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153588 Such as N-butyl-2-(4-(4-chloro-3-methoxyphenyl)-5-pyridin-4-yl-1H-imidazole-2 -yl)isobutylamide for treatment of neurotraumatic disorders
08/14/2003US20030153584 Such as cyclo-D-phenylglycyl-L-(2-(amino-3-mercaptobutanoic acid))
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153573 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
08/14/2003US20030153570 Such as 6(5-chloro-2-methoxyphenyl)-N-(4-chlorophenyl)-(1,3,5) triazine-2,4-diamine for inhibition of lysophosphatidic acid acyltransferase (LLPAAT-SS); antitumor agents
08/14/2003US20030153567 N-phenyl imidazole derivatives
08/14/2003US20030153560 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors
08/14/2003US20030153555 Novel compounds
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153510 Novel compounds inhibiting factor xa activity
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2475320A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/13/2003EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH)
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333832A1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333828A2 Prevention of development of dyskinesias
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0976745B1 4-tetrahydropyridylpyrimidine derivatives
08/13/2003EP0966458B1 Sulfonated xanthene derivatives
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0901478B1 Thiocyano-triazolyl derivatives and their use as microbicides
08/13/2003EP0901477B1 Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
08/13/2003EP0837859B1 Tetrahydrofuran antifungals
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436184A Substd. pyridine herbicides
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections
08/13/2003CN1117748C Herbicidal 2,6-disubstd. pyridines and 2,4-disubstd. pyrimidines
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117741C Heterocyclic fungicides
08/13/2003CN1117737C Symmetrical triazine derivs
08/13/2003CN1117568C Gastrokinetic bicyclie benzamides of 3-or 4-substd. 4-(aminomethyl)-piperidine derivs.
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605717 (2R,2'R,2''R)-tris-(2,3-epoxypropyl)-isocyanurate or (2S,2'S,2''S)-tris-(2,3-epoxypropyl)-isocyanurate
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605124 Naphthol hair dyes for keratinous fibers
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/07/2003WO2003064440A1 Compounds that inhibit factor xa activity
08/07/2003WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064392A1 Process for the manufacture of hmg-coa reductase inhibitors
08/07/2003WO2003064382A2 Process for the manufacture of organic compounds
08/07/2003WO2003063871A1 Phenylpyrimidine amines as ige inhibitors
08/07/2003WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections
08/07/2003WO2003009835A3 Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149093 For therapy of dyspepsia, early satiety, bloating and anorexia
08/07/2003US20030149089 Antibacterial compounds
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149079 Novel benzofuran derivatives
08/07/2003US20030149077 Methods of treating cancer using a heat shock factor activity inhibitor
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 694